Micronutrient deficiencies in inflammatory bowel disease: From A to zinc

Inflammatory Bowel Diseases

Volumn 18, Issue 10, 2012, Pages 1961-1981

  Hwang, Caroline ^a   Ross, Viveca ^a   Mahadevan, Uma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

inflammatory bowel disease; micronutrient deficiencies

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CALCIUM; COLECALCIFEROL; COPPER; CYANOCOBALAMIN; FERRIC CARBOXYMALTOSE; FOLIC ACID; GAMMA TOCOPHEROL; GLUCONATE ZINC; INTERLEUKIN 6; IRON; MENATETRENONE; NICOTINIC ACID; OSTEOCLAST DIFFERENTIATION FACTOR; PYRIDOXINE; PYROGLUTAMATE MAGNESIUM; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOL; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN K GROUP; ZINC; ZINC SULFATE;

ASCORBIC ACID DEFICIENCY; BLEEDING; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; BONE PAIN; CALCIUM DEFICIENCY; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DISEASE ACTIVITY; DNA METHYLATION; DRUG MEGADOSE; FATTY ACID OXIDATION; FOLIC ACID DEFICIENCY; HEADACHE; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; IRON DEFICIENCY ANEMIA; LIVER TOXICITY; MAGNESIUM DEFICIENCY; MALNUTRITION; MEGALOBLASTIC ANEMIA; META ANALYSIS (TOPIC); NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PARENTERAL NUTRITION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; THROMBOPHILIA; TREATMENT DURATION; ULCERATIVE COLITIS; VEIN THROMBOSIS; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN K DEFICIENCY; WOUND HEALING IMPAIRMENT; ZINC DEFICIENCY;

DIETARY SUPPLEMENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MICRONUTRIENTS;

EID: 84866426985     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22906     Document Type: Review

References (162)

1. Mekhjian HS, Switz DM, Melnyk CS, et al. Clinical features and natural history of Crohn's disease. Gastroenterology. 1979; 77 (4 Pt 2): 898-906. (Pubitemid 9257853)
2. Harries AD, Heatley RV,. Nutritional disturbances in Crohn's disease. Postgrad Med J. 1983; 59: 690-697. (Pubitemid 14235538)
3. Dawson AM,. Nutritional disturbances in Crohn's disease. Br J Surg. 1972; 59: 817-819.
4. Dawson AM,. Nutritional disturbances in Crohn's disease. Proc R Soc Med. 1971; 64: 166-170.
5. Filippi J, Al-Jaouni R, Wiroth JB, et al. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 2006; 12: 185-191.
6. Aghdassi E, Wendland BE, Stapleton M, et al. Adequacy of nutritional intake in a Canadian population of patients with Crohn's disease. J Am Diet Assoc. 2007; 107: 1575-1580. (Pubitemid 47302412)
7. Jahnsen J, Falch JA, Mowinckel P, et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2003; 98: 1556-1562. (Pubitemid 36875347)
8. Valentini L, Schaper L, Buning C, et al. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition. 2008; 24: 694-702.
9. Sousa Guerreiro C, Cravo M, Costa AR, et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol. 2007; 102: 2551-2556. (Pubitemid 47631772)
10. Hass DJ, Brensinger CM, Lewis JD, et al. The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol. 2006; 4: 482-488.
11. Vagianos K, Bernstein CN,. Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study. Inflamm Bowel Dis. 2012 [Epub ahead of print].
12. Weiss G, Gasche C,. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010; 95: 175-178.
13. Duerksen DR, Fallows G, Bernstein CN,. Vitamin B12 malabsorption in patients with limited ileal resection. Nutrition. 2006; 22: 1210-1213. (Pubitemid 44692455)
14. Hoffbrand AV, Stewart JS, Booth CC, et al. Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J. 1968; 2: 71-75.
15. Van Gossum A, Cabre E, Hebuterne X, et al. ESPEN guidelines on parenteral nutrition: gastroenterology. Clin Nutr. 2009; 28: 415-427.
16. Beeken WL,. Remediable defects in Crohn disease: a prospective study of 63 patients. Arch Intern Med. 1975; 135: 686-690.
17. Ormerod TP,. Observations on the incidence and cause of anaemia in ulcerative colitis. Gut. 1967; 8: 107-114.
18. Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010; 4: 642-648.
19. Bager P, Befrits R, Wikman O, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011; 46: 304-309.
20. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 47-52. (Pubitemid 43032451)
21. Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006; 12: 123-130.
22. Gasche C,. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000; 6: 142-150, discussion 151.
23. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004; 53: 1190-1197. (Pubitemid 38961976)
24. Kulnigg S, Gasche C,. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther. 2006; 24: 1507-1523. (Pubitemid 44915199)
25. Andrews NC,. Disorders of iron metabolism. N Engl J Med. 1999; 341: 1986-1995. (Pubitemid 30010408)
26. Frazer DM, Anderson GJ,. Iron imports. I. intestinal iron absorption and its regulation. Am J Physiol Gastrointest Liver Physiol. 2005; 289: G631-635. (Pubitemid 41377168)
27. Arnold J, Sangwaiya A, Bhatkal B, et al. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. Eur J Gastroenterol Hepatol. 2009; 21: 425-429.
28. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007; 13: 1545-1553.
29. Weinstock LB, Bosworth BP, Scherl EJ, et al. Crohn's disease is associated with restless legs syndrome. Inflamm Bowel Dis. 2010; 16: 275-279.
30. Coplin M, Schuette S, Leichtmann G, et al. Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clin Ther. 1991; 13: 606-612.
31. Liguori L,. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients. Int J Clin Pharmacol Ther Toxicol. 1993; 31: 103-123.
32. Werner T, Wagner SJ, Martinez I, et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut. 2011; 60: 325-333.
33. Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011; 141: 846, 853.e1- 2.
34. Yakut M, Ustun Y, Kabacam G, et al. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med. 2010; 21: 320-323.
35. Honein MA, Paulozzi LJ, Mathews TJ, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001; 285: 2981-2986. (Pubitemid 32550116)
36. Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989; 84: 744-748. (Pubitemid 19184375)
37. Hodges P, Gee M, Grace M, et al. Vitamin and iron intake in patients with Crohn's disease. J Am Diet Assoc. 1984; 84: 52-58. (Pubitemid 14155359)
38. Vagianos K, Bector S, McConnell J, et al. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr. 2007; 31: 311-319. (Pubitemid 47025695)
39. Lindenbaum J,. Drugs and vitamin B12 and folate metabolism. Curr Concepts Nutr. 1983; 12: 73-87.
40. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003; 9: 2300-2307. (Pubitemid 37321464)
41. McNulty H, Scott JM,. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr. 2008; 99 (Suppl 3): S48-54. (Pubitemid 351936565)
42. Headstrom PD, Rulyak SJ, Lee SD,. Prevalence of and risk factors for vitamin B (12) deficiency in patients with Crohn's disease. Inflamm Bowel Dis. 2008; 14: 217-223. (Pubitemid 351288043)
43. Coull DB, Tait RC, Anderson JH, et al. Vitamin B12 deficiency following restorative proctocolectomy. Colorectal Dis. 2007; 9: 562-566. (Pubitemid 46958551)
44. Carmel R,. Subtle and atypical cobalamin deficiency states. Am J Hematol. 1990; 34: 108-114. (Pubitemid 20180102)
45. Savage DG, Lindenbaum J, Stabler SP, et al. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994; 96: 239-246. (Pubitemid 24099223)
46. Lenz K,. The effect of the site of lesion and extent of resection on duodenal bile acid concentration and vitamin B12 absorption in Crohn's disease. Scand J Gastroenterol. 1975; 10: 241-248.
47. Thompson WG, Wrathell E,. The relation between ileal resection and vitamin B12 absorption. Can J Surg. 1977; 20: 461-464. (Pubitemid 8197011)
48. Vidal-Alaball J, Butler CC, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005; 3: CD004655.
49. Rodriguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK,. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol. 2007; 13: 6156-6165.
50. Lichtenstein GR, Sands BE, Pazianas M,. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 797-813. (Pubitemid 44253764)
51. Bernstein CN,. Inflammatory bowel diseases as secondary causes of osteoporosis. Curr Osteoporos Rep. 2006; 4: 116-123. (Pubitemid 44623934)
52. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000; 133: 795-799.
53. Pappa HM, Grand RJ, Gordon CM,. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006; 12: 1162-1174. (Pubitemid 44847474)
54. Bronner F,. Mechanisms of intestinal calcium absorption. J Cell Biochem. 2003; 88: 387-393. (Pubitemid 36119913)
55. Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002; 23: 552-559. (Pubitemid 34925649)
56. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354: 669-683. (Pubitemid 43247138)
57. Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther. 1996; 10: 777-786. (Pubitemid 26340209)
58. von Tirpitz C, Klaus J, Steinkamp M, et al. Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther. 2003; 17: 807-816. (Pubitemid 36418878)
59. Gilman J, Shanahan F, Cashman KD,. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2006; 23: 1007-1016.
60. McCarthy D, Duggan P, O'Brien M, et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther. 2005; 21: 1073-1083. (Pubitemid 40646532)
61. Siffledeen JS, Siminoski K, Steinhart H, et al. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol. 2003; 17: 473-478. (Pubitemid 37321992)
62. Sentongo TA, Semaeo EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002; 76: 1077-1081. (Pubitemid 35244680)
63. Leslie WD, Miller N, Rogala L, et al. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD cohort study. Am J Gastroenterol. 2008; 103: 1451-1459. (Pubitemid 351813899)
64. Gilman J, Shanahan F, Cashman KD,. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006; 60: 889-896. (Pubitemid 43997702)
65. Haderslev KV, Jeppesen PB, Sorensen HA, et al. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut. 2003; 52: 653-658. (Pubitemid 36528865)
66. Leichtmann GA, Bengoa JM, Bolt MJ, et al. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr. 1991; 54: 548-552. (Pubitemid 21898967)
67. Davies M, Mawer EB, Krawitt EL,. Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease. Gut. 1980; 21: 287-292. (Pubitemid 10056060)
68. Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol. 2004; 39: 527-533. (Pubitemid 38996894)
69. Bartram SA, Peaston RT, Rawlings DJ, et al. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Pharmacol Ther. 2003; 18: 1121-1127. (Pubitemid 38021598)
70. Heaney RP, Recker RR, Grote J, et al. Vitamin D (3) is more potent than vitamin D (2) in humans. J Clin Endocrinol Metab. 2011; 96: E447-452.
71. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911-1130.
72. Reginster JY, Strause L, Deroisy R, et al. Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium. 1989; 8: 106-109. (Pubitemid 19165861)
73. Rude RK, Gruber HE,. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem. 2004; 15: 710-716. (Pubitemid 40018113)
74. Krebs-Smith SM, Cleveland LE, Ballard-Barbash R, et al. Characterizing food intake patterns of American adults. Am J Clin Nutr. 1997; 65 (4 Suppl): 1264S-1268S. (Pubitemid 27152597)
75. Hessov I,. Magnesium deficiency in Crohn's disease. Clin Nutr. 1990; 9: 297-298. (Pubitemid 20348711)
76. Galland L,. Magnesium and inflammatory bowel disease. Magnesium. 1988; 7: 78-83.
77. Jeejeebhoy KN,. Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease. CMAJ. 2002; 166: 913-918. (Pubitemid 34275514)
78. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab. 2004; 89: 4904-4909. (Pubitemid 39391426)
79. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA,. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999; 69: 74-79. (Pubitemid 29031254)
80. Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr. 2003; 77: 512-516. (Pubitemid 36133397)
81. Macdonald HM, McGuigan FE, Lanham-New SA, Fraser WD, Ralston SH, Reid DM,. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr. 2008; 87: 1513-1520. (Pubitemid 351679797)
82. Luukinen H, Kakonen SM, Pettersson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res. 2000; 15: 2473-2478.
83. Szulc P, Arlot M, Chapuy MC, et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 1994; 9: 1591-1595. (Pubitemid 24300109)
84. Kawana K, Takahashi M, Hoshino H, et al. Circulating levels of vitamin K1, menaquinone-4, and menaquinone-7 in healthy elderly Japanese women and patients with vertebral fractures and patients with hip fractures. Endocr Res. 2001; 27: 337-343. (Pubitemid 32952720)
85. Krasinski SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985; 41: 639-643. (Pubitemid 15143910)
86. Duggan P, O'Brien M, Kiely M, et al. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol. 2004; 99: 2178-2185. (Pubitemid 39529771)
87. Kuwabara A, Tanaka K, Tsugawa N, et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int. 2009; 20: 935-9342.
88. Nakajima S, Iijima H, Egawa S, et al. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nutrition. 2011; 27: 1023-1028.
89. Fang Y, Hu C, Tao X, et al. Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. J Bone Miner Metab. 2011; 30: 60-68.
90. Braam LA, Knapen MH, Geusens P, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int. 2003; 73: 21-26. (Pubitemid 37022075)
91. Bolton-Smith C, McMurdo ME, Paterson CR, et al. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res. 2007; 22: 509-519. (Pubitemid 47457427)
92. Shiraki M, Shiraki Y, Aoki C, et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000; 15: 515-521. (Pubitemid 30134096)
93. Iwamoto J, Matsumoto H, Takeda T,. Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials. Clin Drug Investig. 2009; 29: 471-479.
94. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001; 85: 430-434. (Pubitemid 32233013)
95. Nguyen GC, Sam J,. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008; 103: 2272-2280.
96. Ha C, Magowan S, Accortt SJ, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 1445-1451.
97. Bernstein CN, Wajda A, Blanchard JF,. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008; 6: 41-45. (Pubitemid 50008413)
98. Grip O, Svensson PJ, Lindgren S,. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol. 2000; 35: 619-623. (Pubitemid 30441713)
99. Grainge MJ, West J, Card TR,. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010; 375: 657-663.
100. Nguyen GC, Boudreau H, Harris ML, et al. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009; 7: 329-334.
101. den Heijer M, Rosendaal FR, Blom HJ, et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998; 80: 874-877. (Pubitemid 28556684)
102. Cleophas TJ, Hornstra N, van Hoogstraten B, et al. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis. Am J Cardiol. 2000; 86: 1005, 9, A8.
103. Cattaneo M, Vecchi M, Zighetti ML, et al. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost. 1998; 80: 542-545. (Pubitemid 28479334)
104. Mahmood A, Needham J, Prosser J, et al. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2005; 17: 739-744. (Pubitemid 40896420)
105. Papa A, De Stefano V, Danese S, et al. Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol. 2001; 96: 2677-2682.
106. Romagnuolo J, Fedorak RN, Dias VC, et al. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol. 2001; 96: 2143-2149. (Pubitemid 32660911)
107. Ray JG,. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998; 158: 2101-2106. (Pubitemid 28482092)
108. Oldenburg B, Van Tuyl BA, van der Griend R, et al. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Dig Dis Sci. 2005; 50: 235-240. (Pubitemid 40311526)
109. Erzin Y, Uzun H, Celik AF, et al. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications. J Clin Gastroenterol. 2008; 42: 481-486. (Pubitemid 351572253)
110. Kuroki F, Iida M, Tominaga M, et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci. 1993; 38: 1614-1618. (Pubitemid 23271415)
111. Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B (6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003; 98: 112-117. (Pubitemid 36135178)
112. Torres J, de Chambrun GP, Itzkowitz S, et al. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 34: 497-508.
113. Schernhammer ES, Ogino S, Fuchs CS,. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology. 2008; 135: 770-780.
114. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine-low- folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995; 87: 265-273.
115. Konings EJ, Goldbohm RA, Brants HA, et al. Intake of dietary folate vitamers and risk of colorectal carcinoma: results from the Netherlands cohort study. Cancer. 2002; 95: 1421-1433.
116. Meyer F, White E,. Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol. 1993; 138: 225-236. (Pubitemid 23263593)
117. Su LJ, Arab L,. Nutritional status of folate and colon cancer risk: evidence from NHANES I epidemiologic follow-up study. Ann Epidemiol. 2001; 11: 65-72. (Pubitemid 32054790)
118. Lashner BA,. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol. 1993; 119: 549-554. (Pubitemid 23180046)
119. Lashner BA, Heidenreich PA, Su GL, et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology. 1989; 97: 255-259. (Pubitemid 19192158)
120. Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 1997; 112: 29-32. (Pubitemid 27008982)
121. Biasco G, Zannoni U, Paganelli GM, et al. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev. 1997; 6: 469-471. (Pubitemid 27270553)
122. Garland CF, Garland FC,. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980; 9: 227-231. (Pubitemid 11238851)
123. Fedirko V, Bostick RM, Goodman M, et al. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol. 2010; 172: 489-500.
124. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ. 2010; 340: b5500.
125. Lee JE, Li H, Chan AT, et al. Circulating levels of vitamin D and colon and rectal cancer: the physicians' health study and a meta-analysis of prospective studies. Cancer Prev Res (Phila). 2011; 4: 735-743.
126. Woolcott CG, Wilkens LR, Nomura AM, et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2010; 19: 130-134.
127. Tangpricha V, Flanagan JN, Whitlatch LW, et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001; 357: 1673-1674. (Pubitemid 32568244)
128. Fedirko V, Bostick RM, Long Q, et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2010; 19: 280-291.
129. Di Rosa M, Malaguarnera M, Nicoletti F, et al. Vitamin D3: a helpful immuno-modulator. Immunology. 2011; 134: 123-139.
130. Froicu M, Cantorna MT,. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007; 8: 5.
131. Cantorna MT, Munsick C, Bemiss C, et al. 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000; 130: 2648-2652.
132. Simmons JD, Mullighan C, Welsh KI, et al. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut. 2000; 47: 211-214. (Pubitemid 30489764)
133. Eloranta JJ, Wenger C, Mwinyi J, et al. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics. 2011; 21: 559-564.
134. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006; 354: 684-696. (Pubitemid 43247139)
135. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003; 95: 1765-1771. (Pubitemid 38008899)
136. Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010; 32: 377-383.
137. Carroll C, Cooper K, Papaioannou D, et al. Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther. 2010; 32: 789-803.
138. Wu K, Willett WC, Fuchs CS, et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 2002; 94: 437-446. (Pubitemid 34285093)
139. Martinez ME, Willett WC,. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 1998; 7: 163-168. (Pubitemid 28109849)
140. Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004; 96: 1015-1022. (Pubitemid 39162644)
141. Baron JA, Beach M, Mandel JS, et al. Calcium supplements and colorectal adenomas. polyp prevention study group. Ann N Y Acad Sci. 1999; 889: 138-145. (Pubitemid 30040433)
142. Sinno S, Lee DS, Khachemoune A,. Vitamins and cutaneous wound healing. J Wound Care. 2011; 20: 287-293.
143. Anstead GM,. Steroids, retinoids, and wound healing. Adv Wound Care. 1998; 11: 277-285.
144. D'Odorico A, Bortolan S, Cardin R, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol. 2001; 36: 1289-1294. (Pubitemid 33027808)
145. Hengstermann S, Valentini L, Schaper L, et al. Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease. Clin Nutr. 2008; 27: 571-578.
146. Lansdown AB, Mirastschijski U, Stubbs N, et al. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen. 2007; 15: 2-16. (Pubitemid 46146657)
147. Jacob RA, Swendseid ME, McKee RW, et al. Biochemical markers for assessment of niacin status in young men: urinary and blood levels of niacin metabolites. J Nutr. 1989; 119: 591-598. (Pubitemid 19116775)
148. Ramakrishna BS, Varghese R, Jayakumar S, et al. Circulating antioxidants in ulcerative colitis and their relationship to disease severity and activity. J Gastroenterol Hepatol. 1997; 12: 490-494. (Pubitemid 27306002)
149. Finley JW, Davis CD, Feng Y,. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr. 2000; 130: 2384-2389.
150. Lane HW, Medina D, Wolfe LG,. Proposed mechanisms for selenium-inhibition of mammary tumorigenesis (review). In Vivo. 1989; 3: 151-160. (Pubitemid 19179987)
151. Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2011; 5: CD005195.
152. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr. 2000; 54: 514-521. (Pubitemid 30345403)
153. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998; 67: 919-926. (Pubitemid 28196667)
154. Sturniolo GC, Mestriner C, Lecis PE, et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol. 1998; 33: 644-649. (Pubitemid 28300247)
155. Ringstad J, Kildebo S, Thomassen Y,. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol. 1993; 28: 605-608. (Pubitemid 23192690)
156. Fernandez-Banares F, Mingorance MD, Esteve M, et al. Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. Am J Gastroenterol. 1990; 85: 1584-1589.
157. Mueller C, Compher C, Ellen DM, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr. 2011; 35: 16-24.
158. Jeejeebhoy KN, Chu RC, Marliss EB, et al. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977; 30: 531-538. (Pubitemid 8083749)
159. Jeejeebhoy KN,. Zinc and chromium in parenteral nutrition. Bull N Y Acad Med. 1984; 60: 118-124. (Pubitemid 14173931)
160. Hardy G,. Manganese in parenteral nutrition: who, when, and why should we supplement? Gastroenterology. 2009; 137 (5 Suppl): S29-35.
161. Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. AMA Department of Foods and Nutrition. JAMA. 1979; 241: 2051-2054.
162. Btaiche IF, Carver PL, Welch KB,. Dosing and monitoring of trace elements in long-term home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2011; 35: 736-747.